The National Agency for Food and Drug Administration and Control (NAFDAC) has reaffirmed its commitment to ensuring that the importation of antileprosy medicine, specifically Rifampicin, adheres to due process. This move aims to guarantee the quality, safety, and efficacy of the medicine. NAFDAC has implemented guidelines for the importation of Active Pharmaceutical Ingredients (APIs) and […]

The post NAFDAC Clarifies Stance On Importing Antileprosy Medication appeared first on Information Nigeria.